These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


763 related items for PubMed ID: 19022818

  • 1. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
    Kay J.
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.
    Bernstein EJ, Schmidt-Lauber C, Kay J.
    Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):489-503. PubMed ID: 23040363
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.
    Lim YL, Lee HY, Low SC, Chan LP, Goh NS, Pang SM.
    Clin Exp Dermatol; 2007 Jul; 32(4):353-8. PubMed ID: 17433041
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.
    Todd DJ, Kagan A, Chibnik LB, Kay J.
    Arthritis Rheum; 2007 Oct; 56(10):3433-41. PubMed ID: 17907148
    [Abstract] [Full Text] [Related]

  • 12. Gadolinium and nephrogenic systemic fibrosis: have we overreacted?
    Penfield JG, Reilly RF.
    Semin Dial; 2011 Oct; 24(5):480-6. PubMed ID: 21913988
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists.
    Prasad SR, Jagirdar J.
    J Comput Assist Tomogr; 2008 Oct; 32(1):1-3. PubMed ID: 18303280
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Safety of older generations of gadolinium in mild-to-moderate renal failure.
    Khatami SM, Mahmoodian M, Zare E, Pashang M.
    Ren Fail; 2012 Oct; 34(2):176-80. PubMed ID: 22260266
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Current status of nephrogenic systemic fibrosis.
    Daftari Besheli L, Aran S, Shaqdan K, Kay J, Abujudeh H.
    Clin Radiol; 2014 Jul; 69(7):661-8. PubMed ID: 24582176
    [Abstract] [Full Text] [Related]

  • 20. [Nephrogenic systemic fibrosis and use of MR contrast media].
    Christiansen RE, Sviland L, Sekse I, Svarstad E.
    Tidsskr Nor Laegeforen; 2009 Jan 29; 129(3):180-2. PubMed ID: 19180161
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 39.